Tweet
<img alt="" height="1" width="1" />
All-Oral Tx Proves Safe in Untreated MM
MedPage Today
This study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. An all-oral treatment that included an investigational proteasome inhibitor ...
Takeda 'oral Velcade' Posts Strong Results in Multiple Myeloma StudyTheStreet.com
Takeda's oral successor to Velcade benefits blood cancer patientsFierceBiotech
New Oral Drug in Multiple Myeloma May Be 'Game Changer'Medscape
OncLive -National Post
all 19 news articles »
More...